Abstract
Verruconis gallopava is a dematiaceous mould usually causing saprophytic infection in immunosuppressed host. Only a few cases have been published even in immunocompromised states. We present a rare case of pulmonary involvement in an immunocompetent patient with recurrent disease. The mid-aged woman had no evidence of any disease causing impaired immune response. Recurrent disease shows pulmonary infiltrates and symptoms of allergic bronchopulmonary mycosis. We describe an emerging pathogen that has been found in an immunocompetent host. Eradication was not possible despite the use of several different antifungal drugs. Further recurrence of infection in the described patient is probable.
This is a preview of subscription content, log in via an institution to check access.
References
Shoham S, Pic-Aluas L, Taylor J, Cortez K, Rinaldi MG, Shea Y, Walsh TJ. Transplant-associated Ochroconis gallopava infections. Transpl Infect Dis. 2008;10:442–8.
Rossmann SN, Cernoch PL, Davis JR. Dematiaceous fungi are an increasing cause of human disease. Clin Infect Dis. 1996;22:73–80.
Singh N, Chang FY, Gayowski T, Marino IR. Infections due to dematiaceous fungi in organ transplant recipients: case report and review. Clin Infect Dis. 1997;24:369–74.
Meriden Z, Marr KA, Lederman HM, Illei PB, Villa K, Riedel S, Caroll KC, Zhang SX. Ochroconis gallopava infection in a patient with chronic granulomatous disease: case report and review of the literature. Med Mycol. 2012;50:883–9.
Mayer N, Bastani B. A case of pulmonary cavitary lesion due to Dactylaria constricta var. gallopava in a renal transplant patient. Nephrology. 2009;14:262.
Burns KEA, Ohori NP, Iacono AT. Dactylaria gallopava infection presenting as a pulmonary nodule in a single-lung transplant recipient. J Heart Lung Transplant. 2000;19:900–2.
Mancini MC, McGinnis MR. Dactylaria infection of a human being: pulmonary disease in a heart transplant recipient. J Heart Lung Transpl. 1992;11:827–30.
Wang TK, Chiu W, Chim S, Chan TM, Wong SS, Ho PL. Disseminated Ochroconis gallopavum infection in a renal transplant recipient: the first reported case and a review of the literature. Clin Nephrol. 2003;60:415–23. doi:10.5414/CNP60415.
Sides EH, Benson JD, Padhye AA. Phaeohyphomycotic brain abscess due to Ochroconis gallopavum in a patient with malignant lymphoma of a large cell type. J Med Vet Mycol. 1991;29:317–22.
Fukushima N, Mannen K, Okamoto S, Shinogi T, Nishimoto K, Sueoka E. Disseminated Ochroconis gallopavum infection in a chronic lymphocytic leukemia: a case report and review of the literature on hematological malignancies. Intern Med. 2005;44:879–82.
Qureshi ZA, Kwak EJ, Nguyen MH, Silveira FP. Ochroconis gallopava: a dematiaceous mold causing infections in transplant recipients. Clin Transplant. 2012;26:E17–23.
Odell JA, Alvarez S, Cvitkovich DG, Cortese DA, McComb BL. Multiple lung abscesses due to Ochroconis gallopavum, a dematiaceous fungus, in a nonimmunocompromised wood pulp worker. Chest. 2000;118:1503–5.
Hollingsworth JW, Shofer S, Zaas A. Successful treatment of Ochroconis gallopavum infection in an immunocompetent host. Infection. 2007;35:367–9.
Samerpitak K, Van der Linde E, Choi HJ, Gerrits van den Ende AHG, Machouart M, Gueidan C, de Hoog GS. Taxonomy of Ochroconis, genus including opportunistic pathogens on humans and animals. Fungal Divers. 2014;65:89–126. doi:10.1007/s13225-013-0253-6.
Lass-Flörl C, Mayr A, Perkhofer S, Hinterberger G, Hausdorfer J, Speth C, Fille M. Activities of antifungal agents against yeasts and filamentous fungi: assessment according to the methodology of the European Committee on Antimicrobial Susceptibility Testing. Antimicrob Agents Chemother. 2008;52:3637–41. doi:10.1128/AAC.00662-08 [Epub 2008 Aug 11].
Giraldo A, Sutton DA, Samerpitak K, de Hoog GS, Wiederhold NP, Guarro J, Gené J. Occurrence of Ochroconis and Verruconis species in clinical specimens from the United States. J Clin Microbiol. 2014;52:4189–201. doi:10.1128/JCM.02027-14 [Epub 2014 Sep 17].
Seyedmousavi S, Samerpitak K, Rijs AJM, Melchers WJG, Mouton JW, Verweij PE, de Hoog GS. Antifungal Susceptibility Patterns of Opportunistic Fungi in the Genera Verruconis and Ochroconis. Antimicrob Agents Chemother. 2014;58:3285–92.
Walsh TJ, Anaissie EJ, Denning DW, Herbrecht R, Kontoyian-nis DP, Marr KA, Morrison VA, Segal BH, Steinbach WJ, Stevens DA, Van Burik JA, Wingard JR, Patterson TF. Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis. 2008;46:327–60.
Fricker-Hidalgo H, Coltey B, Llerena C, Renversez JC, Grillot R, Pin I, Pelloux H, Pinel C. Recombinant allergens combined with biological markers in the diagnosis of allergic bronchopulmonary aspergillosis in cystic fibrosis patients. Clin Vaccine Immunol. 2010;17:1330–6. doi:10.1128/CVI.00200-10.
Conflict of interest
None for this case report.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Geltner, C., Sorschag, S., Willinger, B. et al. Necrotizing mycosis due to Verruconis gallopava in an immunocompetent patient. Infection 43, 743–746 (2015). https://doi.org/10.1007/s15010-015-0757-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s15010-015-0757-y